4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001140361-21-022931
Chief Medical Officer acquired 201 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Whiting Samuel Chief Medical Officer | 2021-06-25 | Grant or award | +201 | 201 | D | ||
| Derivatives | |||||||
| Whiting Samuel Chief Medical Officer | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +61,945 | 61,945 | D | ||
| Whiting Samuel Chief Medical Officer | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +3,018 | 3,018 | D | ||
| Whiting Samuel Chief Medical Officer | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +540,231 | 540,231 | D | ||
Loading xslF345X03/form4.xml…